Annovis Bio Inc expected to post a loss of 33 cents a share - Earnings Preview

Annovis Bio

28/04/2023 18:36

* Annovis Bio Inc  ANVS.N   ANVS.K  is expected to report
results on May 2 (estimated).
    * 
    * ​Refinitiv's mean analyst estimate for Annovis Bio Inc is
for a
loss of 33 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had risen by
about 1.9%
in the last three months. ​
    * Wall Street's median 12-month price target for Annovis Bio
Inc
is $40​, above​ its last closing price of $15.03. ​​​

This summary was machine generated April 28 at 17:36 GMT.  All
figures in US dollars  unless otherwise stated